Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health”

1,166 pharma patents match "The United States of America, as represented by the Secretary, Department of Health" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,166
Index total 30,257
Page 42 / 49

Quick answer

This filtered view shows 1,166 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,166 results for “The United States of America, as represented by the Secretary, Department of Health” · 30,257 patents in full index Clear search

  1. US 8754081

    Compositions and methods for inhibition of hepatocyte growth factor receptor c-Met signaling

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  2. US 8754046

    MHC class II restricted T cell epitopes from the cancer anitgen, NY ESO-1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  3. US 8753649

    Polysaccharide-protein conjugate vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  4. US 8748390

    Immunogenic epitopes of NGEP antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  5. US 8748572

    RNase a peptides, fragments and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  6. US 8741649

    Methods for enhancing genome stability and telomere elongation in embryonic stem cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 3, 2014 · Expires May 29, 2034

    granted

  7. US 8741313

    Polypeptide vaccine and vaccination strategy against mycobacterium

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 3, 2014 · Expires May 29, 2034

    granted

  8. US 8735126

    Disease control with tick phospholipase A2

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 27, 2014 · Expires May 22, 2034

    granted

  9. US 8735082

    Gene signature for predicting prognosis of patients with solid tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 27, 2014 · Expires May 22, 2034

    granted

  10. US 8728488

    Methods of inducing an immune response in a host by administering flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted May 20, 2014 · Expires May 15, 2034

    granted

  11. US 8722653

    Method for treating uterine fibroids

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 13, 2014 · Expires May 8, 2034

    granted

  12. US 8715686

    Conformationally stabilized HIV envelope immunogens

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 6, 2014 · Expires May 1, 2034

    granted

  13. US 8716301

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 6, 2014 · Expires May 1, 2034

    granted

  14. US 8709813

    DNA promoters and anthrax vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  15. US 8710026

    MiR 204, miR 211, their anti-miRs, and therapeutic uses of same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  16. US 8703150

    Methods of using Bacillus anthracis protective antigen sequences for vaccination

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  17. US 8703921

    Compositions and methods for delivering inhibitory oligonucleotides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  18. US 8697666

    Anti-cancer oligodeoxynucleotides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  19. US 8697046

    Methods of administering interferon gamma to absorb fluid from the subretinal space

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  20. US 8685722

    Bovine adeno-associated viral (BAAV) vector and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  21. US 8686016

    Schweinfurthins and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  22. US 8685396

    Monoclonal antibodies that neutralize anthrax protective antigen (PA) toxin

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  23. US 8685416

    Compositions and methods for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  24. US 8680056

    Antiproliferative factor and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.